Table 3 The age-adjusted incidence of pancreatic signet ring cell carcinoma (PSRCC) in Surveillance, Epidemiology and End Results (SEER) 2000–2018
Variables | Incidencea | 95% CI |
|---|---|---|
Overall | 0.349 | 0.321–0.379 |
Age at diagnosis | ||
15–19 | 0.009 | 0–0.049 |
20–24 | 0.000 | 0–0.032 |
25–29 | 0.009 | 0–0.049 |
30–34 | 0.009 | 0–0.049 |
35–39 | 0.062 | 0.025–0.127 |
40–44 | 0.139 | 0.079–0.225 |
45–49 | 0.192 | 0.102–0.290 |
50–54 | 0.356 | 0.253–0.487 |
55–59 | 0.680 | 0.526–0.865 |
60–64 | 1.085 | 0.868–1.340 |
65–69 | 1.720 | 1.410–2.079 |
70–74 | 1.814 | 1.453–2.237 |
75–79 | 2.116 | 1.675–2.637 |
80–84 | 1.451 | 1.037–1.976 |
85+ | 1.282 | 0.888–1.792 |
Sex | ||
Male | 0.420 | 0.375–0.470 |
Female | 0.287 | 0.253–0.325 |
Race | ||
White | 0.359 | 0.328–0.393 |
Black | 0.369 | 0.280–0.475 |
Other | 0.220 | 0.057–0.569 |
Year of diagnosis | ||
2000–2009 | 0.409 | 0.366–0.457 |
2010–2018 | 0.293 | 0.258–0.331 |
Primary site | ||
Head | 0.162 | 0.144–0.183 |
Body | 0.037 | 0.028–0.047 |
Tail | 0.050 | 0.040–0.062 |
Other | 0.026 | 0.019–0.035 |